贛鋒鋰業(002460.SZ):擬投資84億元建年產15GWh新型鋰電池項目
格隆匯8月5日丨贛鋒鋰業(002460.SZ)公佈,公司於2021年8月5日召開的第五屆董事會第三十二次會議審議通過了《關於贛鋒鋰電投資建設年產15GWh新型鋰電池項目的議案》,同意公司控股子公司江西贛鋒鋰電科技有限公司(“贛鋒鋰電”)以自有資金投資84億元人民幣建設年產15GWh新型鋰電池項目。
其中在江西新餘高新技術產業開發區投資30億元人民幣建設年產5GWh新型鋰電池項目、在重慶兩江新區新設獨立法人主體的項目公司投資54億元人民幣建設年產10GWh新型鋰電池科技產業園及先進電池研究院項目。授權公司經營層全權辦理本次投資的相關手續,並簽署相關法律文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.